Announcements Trials
Browse Landscape

Status

No longer available 4Approved for marketing 2Available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 15Lymphoid 13Tumor-Agnostic 12Other hematologic neoplasm 12Gastrointestinal 12Thoracic 11Sarcoma 11Genitourinary 11Myeloid 7Breast 7Plasma cell 6Gynecologic 6Head & Neck 5Dermatologic 5Endocrine 4Other solid neoplasm 2NET 1Classical hematology 1

Conditions

Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Liposarcoma 1Insulinoma 1Hypoglycemia 1Hyperinsulinism 1Fibrosarcoma 1Adenoma, Islet Cell 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Expanded_access × NET × Clear all
NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Rezolute

Available
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡